March 30 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 30
points higher at 6,767 on Tuesday, according to financial bookmakers.
* GLAXOSMITHKLINE: GlaxoSmithKline GSK.L has agreed in principle to handle
the final part of the manufacturing process for up to 60 million doses of
Novavax 's NVAX.O COVID-19 vaccine for use in Britain, widening the company's
role in the fight against the pandemic. * ASTRAZENECA: Canadian health officials said on Monday they would stop
offering AstraZeneca (NASDAQ:AZN)'s AZN.L COVID-19 vaccine to people under age 55 and
require a new analysis of the shot's risks and benefits based on age and
gender. * IPO: Brazilian energy firm Raizen, a joint venture between Cosan SA
CSAN3.SA and Royal Dutch Shell PLC RDSa.L , has chosen four investment banks
to manage its initial public offering, raising up to 13 billion reais, four
people familiar with the matter said on Monday. * GOLD: Gold prices slipped weighed down by a firm U.S. dollar and Treasury
yields as expectations of a swift economic turnaround grew with vaccination
rates gaining traction. * OIL: Oil prices fell as shipping traffic resumed through the Suez Canal
after days on hold and attention switched to an OPEC+ meeting this week where
the extension of supply curbs may be on the table amid new coronavirus pandemic
lockdowns. * The UK blue-chip index .FTSE closed 0.08% lower on Monday, as weakness
in banks and consumer discretionary stocks outweighed gains in defensive
sectors. UK CORPORATE DIARY:
Royal Mail RMG.L Trading statement
Pennon Group PNN.L Trading statement
A.G. Barr BAG.L FY results
Imperial Brands IMB.L Trading statement
* For more on the factors affecting European stocks, please click on:
LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB